Zydus Cadila receives USFDA approval for Doxazosin tablets
Zydus Cadila has received final USFDA approval to market Doxazosin tablets, used for treatment of high blood pressure and urinary retention associated with enlargement of […]
FDA
Zydus Cadila receives USFDA approval for Acylovir
Zydus Cadila has received final USFDA approval to market Acylovir drug for injection USP in strengths of 500 mg/vial and 1000 mg/vial. The drug is […]
Jubilant Life Sciences receives USFDA approval for Bupropion Hydrochloride
Jubilant Life Sciences through its subsidiary has received final USFDA approval for Bupropion Hydrochloride extended-release tablets, used for the treatment of major depressive disorder and […]
Zydus Cadila to market oxybutynin chloride tablets in USA
Zydus Cadila has received final USFDA approval to market oxybutynin chloride tablets in USA. The drug is used to treat overactive bladder and urinary incontinence […]
Glenmark receives USFDA approval for Indomethacin tablets
Glenmark Pharmaceuticals has received final USFDA approval for its generic version of anti-inflammatory drug Indomethacin tablets. The drug is the generic equivalent of Indocin SR […]
Natco Pharma receives USFDA approval for Vidaza
Natco Pharma Ltd has got the final USFDA approval for the generic version of Vidaza (Azacitidine for injection, 100 mg per vial), single-dose vial. Natco […]
Lupin receives USFDA approval to market Tobi in US
Lupin has received final USFDA approval to market a generic version of Novartis’ inhalation product Tobi, which is used to treat cystic fibrosis, in the […]
Unichem Laboratories receives USFDA approval for Piroxicam
Unichem Laboratories has received final USFDA approval for Piroxicam capsules, used in the treatment of osteoarthritis and rheumatoid arthritis, in the US market. The approved […]
Alembic Pharma receives USFDA approval for fenofibric acid delayed release capsules
Alembic Pharmaceuticals has received final USFDA approval for Fenofibric acid delayed-release capsules used for lowering high cholesterol and increasing good cholesterol. The approved product is […]
Alembic receives USFDA approval for olmesartan and hydrochlorothiazide
Alembic Pharmaceuticals has received final USFDA approval for two anti-hypertension tablets – olmesartan medoxomil tablets, 5 mg, 20 mg, and 40 mg and olmesartan medoxomil […]